124 related articles for article (PubMed ID: 2204310)
1. Necrotizing vasculitis at granulocyte-macrophage-colony-stimulating factor injection sites.
Farmer KL; Kurzrock R; Gutterman JU; Duvic M
Arch Dermatol; 1990 Sep; 126(9):1243-4. PubMed ID: 2204310
[No Abstract] [Full Text] [Related]
2. GM-CSF: intravenous versus subcutaneous treatment.
Aglietta M; Monzeglio C; Piacibello W; Aprá F; Stacchini A; Sanavio F; Mossetti C; Stern AC; Gavosto F
Leukemia; 1990 Jul; 4(7):523. PubMed ID: 2197516
[No Abstract] [Full Text] [Related]
3. Granulocyte-macrophage colony-stimulating factor and vasculitis.
Dreicer R; Schiller JH; Carbone PP
Ann Intern Med; 1989 Jul; 111(1):91-2. PubMed ID: 2660649
[No Abstract] [Full Text] [Related]
4. Clinical studies of granulocyte-macrophage colony stimulating factor.
Gutterman J
Semin Oncol; 1988 Oct; 15(5 Suppl 5):52-3. PubMed ID: 3057645
[No Abstract] [Full Text] [Related]
5. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.
Champlin RE; Nimer SD; Oette D; Golde DW
Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137
[No Abstract] [Full Text] [Related]
6. [GM-CSF: granulocyte and macrophage colony stimulating factor. A biologic agent with a great therapeutic potential in oncology].
Cortes-Funes H
Rev Clin Esp; 1990 Mar; 186(4):173-4. PubMed ID: 2195605
[No Abstract] [Full Text] [Related]
7. Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis.
Hazenberg BP; Van Leeuwen MA; Van Rijswijk MH; Stern AC; Vellenga E
Blood; 1989 Dec; 74(8):2769-70. PubMed ID: 2510837
[No Abstract] [Full Text] [Related]
8. Nursing care of AIDS patients participating in a Phase I/II trial of recombinant human granulocyte-macrophage colony stimulating factor.
Lynch M; Yanes L; Todd K
Oncol Nurs Forum; 1988; 15(4):463-9. PubMed ID: 3041383
[No Abstract] [Full Text] [Related]
9. GM-CSF in combination with cytotoxic chemotherapy in AML patients.
Bettelheim P; Muhm M; Valent P; Geissler K; Andreeff M; Haimi J; Sillaber C; Hinterberger W; Vieder L; Schulz G
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():127-30. PubMed ID: 2202464
[No Abstract] [Full Text] [Related]
10. [GM-CSF: its clinical administration; the treatment of aplasia].
Rossi Ferrini P; Grossi A; Santini V; Vannucchi AM
Haematologica; 1989 Oct; 74(5 Suppl):489-500. PubMed ID: 2512231
[No Abstract] [Full Text] [Related]
11. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
Antman KS; Griffin JD; Elias A; Socinski MA; Ryan L; Cannistra SA; Oette D; Whitley M; Frei E; Schnipper LE
N Engl J Med; 1988 Sep; 319(10):593-8. PubMed ID: 3045544
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor: a teaching program for staff and patients.
Woolery-Antill M
J Pediatr Oncol Nurs; 1990 Apr; 7(2):61. PubMed ID: 2194506
[No Abstract] [Full Text] [Related]
13. Recurrent spleen enlargement during cyclic granulocyte-macrophage colony-stimulating factor therapy for myelodysplastic syndrome.
Delmer A; Karmochkine M; Cadiou M; Gerhartz H; Zittoun R
Am J Hematol; 1990 May; 34(1):73-4. PubMed ID: 2183595
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.
Morstyn G; Lieschke GJ; Sheridan W; Layton J; Cebon J; Fox RM
Semin Hematol; 1989 Apr; 26(2 Suppl 2):9-13. PubMed ID: 2471275
[TBL] [Abstract][Full Text] [Related]
15. AIDS file. GM-CSF may boost WBC counts.
Conover AC
Am J Nurs; 1990 Apr; 90(4):29. PubMed ID: 2181877
[No Abstract] [Full Text] [Related]
16. Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy.
Lieschke GJ; Maher D; Cebon J; O'Connor M; Green M; Sheridan W; Boyd A; Rallings M; Bonnem E; Metcalf D
Ann Intern Med; 1989 Mar; 110(5):357-64. PubMed ID: 2644886
[TBL] [Abstract][Full Text] [Related]
17. Clinical role of granulocyte-macrophage colony-stimulating factor.
Mitsuyasu RT; Golde DW
Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.
Thompson JA; Lee DJ; Kidd P; Rubin E; Kaufmann J; Bonnem EM; Fefer A
J Clin Oncol; 1989 May; 7(5):629-37. PubMed ID: 2651578
[TBL] [Abstract][Full Text] [Related]
19. Clinical applications of colony-stimulating factors.
Groopman JE
Semin Oncol; 1988 Dec; 15(6 Suppl 6):27-33. PubMed ID: 2462748
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic growth factors: biology and clinical application.
Gabrilove JL; Jakubowski A
J Natl Cancer Inst Monogr; 1990; (10):73-7. PubMed ID: 1693284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
